We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-24.29%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$20.8M
AUM Growth
-$11.6M
Cap. Flow
-$4.89M
Cap. Flow %
-23.53%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$4.22M
2
AGTC
Applied Genetic Technologies Corporation
AGTC
+$381K
3
VERO
Venus Concept
VERO
+$290K

Sector Composition

Rank Sector Weight
1 Healthcare 85.85%
2 Consumer Discretionary 14.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$59.2M
$14M 67.54%
1,614,911
– –
SERA icon
2
Sera Prognostics
SERA
$79.5M
$3.04M 14.64%
2,416,241
– –
REAL icon
3
The RealReal
REAL
$1.37B
$2.94M 14.15%
2,354,080
– –
GKOS icon
4
Glaukos
GKOS
$8.73B
$714K 3.43%
16,347
– –
DARE icon
5
Dare Bioscience
DARE
$19M
$51.5K 0.25%
5,172
– –
VERO
6
DELISTED
Venus Concept
VERO
– –
-3,992
Closed -$290K
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-18,700
Closed -$4.22M
AGTC
8
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-1,404,515
Closed -$381K

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q4 2022 Portfolio in Review

As of Q4 2022, InterWest Venture Management held 8 positions worth $20.8M, down 36% from $32.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $4.89M in Q4 2022, closing 3 positions. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $4.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 89% a quarter earlier, followed by Consumer Discretionary.

  • InterWest Venture Management fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $4.22M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $20.8M portfolio in Q4 2022.
  • InterWest Venture Management opened 0 new positions and closed 3 in Q4 2022.
  • InterWest Venture Management's portfolio value fell 36% quarter-over-quarter to $20.8M.

Based on InterWest Venture Management's 13F filing for Q4 2022, filed 31 Jan 2023.